Patents Assigned to Bard Shannon Limited

In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11883276

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: January 30, 2024

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11883275

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: January 30, 2024

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11844684

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: December 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11844683

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: December 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11844682

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: December 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11844686

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: December 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11844685

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: December 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11759306

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: September 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11759307

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: April 21, 2021

Date of Patent: September 19, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
In vivo tissue engineering devices, methods and regenerative and cellular medicine employing scaffolds made of absorbable material

Patent number: 11638640

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Grant

Filed: March 23, 2020

Date of Patent: May 2, 2023

Assignee: Bard Shannon Limited

Inventor: Robert D. Rehnke
COMPOSITION AND METHOD FOR CONTROLLED DRUG RELEASE FROM A TISSUE

Publication number: 20220331492

Abstract: A composition, comprising a hydrogel matrix and microparticles within said matrix, said matrix comprising a cross-linkable protein and a cross-linking agent, wherein said cross-linking agent is able to cross-link said cross-linkable protein, wherein said microparticles comprise a drug.

Type: Application

Filed: May 10, 2022

Publication date: October 20, 2022

Applicant: Bard Shannon Limited

Inventors: Guy Tomer, Aurelie Benaddi, Moriah Anouchi, Amir Hadid
MESH-BASED IN SITU CROSS-LINKABLE COMPOSITIONS

Publication number: 20220126000

Abstract: A mesh-based composition comprising a cross-linkable protein or polypeptide and one or more cross-linking materials according to at least some embodiments. The mesh-based composition may comprise a self-adhering surgical mesh which requires no additional fixation while at the same time minimizes adhesions. The mesh may be in the form of a composite mesh featuring a foamed composition of the cross-linkable protein and a non-toxic material that induces cross-linking of the cross-linkable protein. The composite mesh may be in a sheet-like form.

Type: Application

Filed: November 5, 2021

Publication date: April 28, 2022

Applicant: Bard Shannon Limited

Inventors: Orahn Preiss-Bloom, Guy Tomer, Amir Hadid, Alon Polakewicz, Ariel Maizler, Denis Kramarenko, Daniella Goder, Danny Yosufov
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210290361

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: September 23, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210290366

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: September 23, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210290362

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: September 23, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210290364

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: September 23, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210290365

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: September 23, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210290363

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: September 23, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210251742

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: August 19, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke
IN VIVO TISSUE ENGINEERING DEVICES, METHODS AND REGENERATIVE AND CELLULAR MEDICINE EMPLOYING SCAFFOLDS MADE OF ABSORBABLE MATERIAL

Publication number: 20210236264

Abstract: Tissue engineering devices and methods employing scaffolds made of absorbable material for use in the human body for tissue genesis and regenerative and cellular medicine including breast reconstruction and cosmetic and aesthetic procedures and supplementing organ function in vivo.

Type: Application

Filed: April 21, 2021

Publication date: August 5, 2021

Applicant: Bard Shannon Limited

Inventor: Robert D. Rehnke

1 2 3 next